William Fearon, MD
Academic Appointments
- Associate Professor - Med Center Line, Medicine - Cardiovascular Medicine
Key Documents
Contact Information
-
Clinical Offices
Cardiovascular Medicine Clinic 300 Pasteur Dr MC 5319 A260 Stanford, CA 94305 Tel Work (650) 725-2621 Fax (650) 725-6766
- Academic Offices
Personal Information EmailNot for medical emergencies or patient use
Professional Overview
Clinical Focus
- Interventional Cardiology
- Coronary Artery Disease
- Percutaneous aortic valve
- Aortic Stenosis
- Coronary Physiology
- Cardiology
Administrative Appointments
- Director, Interventional Cardiology, Stanford University Medical Center (2013 - present)
Professional Education
| Fellowship: | Stanford University School of Medicine CA (2002) |
| Fellowship: | Stanford University School of Medicine CA (1998) |
| Residency: | Stanford University School of Medicine CA (1997) |
| Board Certification: | Cardiovascular Disease, American Board of Internal Medicine (2001) |
| Board Certification: | Interventional Cardiology, American Board of Internal Medicine (2002) |
| Internship: | Stanford University Medical Center CA (1995) |
Graduate & Fellowship Program Affiliations
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Current Research Interests
Dr. Fearon's general research interest is coronary physiology. In particular, he is investigating invasive methods for evaluating the coronary microcirculation. His research is currently funded by an NIH R01 Award.
Clinical Trials
- Recruiting Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy
- Not Recruiting FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
- Not Recruiting TAXUS Libertē Post Approval Study
- Not Recruiting Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)
Publications
- Prognostic Value of the Index of Microcirculatory Resistance Measured after Primary Percutaneous Coronary Intervention. Circulation. 2013
- Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012; (11): 991-1001
- Functional SYNTAX score for risk assessment in multivessel coronary artery disease. J Am Coll Cardiol. 2011; (12): 1211-8
- Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. Circulation. 2010; (24): 2545-50
- Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009; (3): 213-24
- Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2008; (5): 560-5
Help